Clinical Trials Browser

Phase 2 × Meningeal Neoplasms × Methotrexate × Clear all

NCT02422641 2026-03-18

Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis

Phase 2 Recruiting

Breast Neoplasms, Meningeal Neoplasms